Assessment of heterogeneity and disease onset in the Parkinson’s Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional study

Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, Carly M. Farris, Yihua Ma, Paula A. Urenia, Hieu Nguyen, Roy N. Alcalay, Lana M. Chahine, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, John Seibyl, Tanya Simuni, Caroline M. Tanner, Daniel Weintraub, Aleksandar Videnovic, Seung Ho Choi, Ryan Kurth, Chelsea Caspell-Garcia, Christopher S. Coffey, Mark Frasier, Luis M. A. Oliveira, Samantha J. Hutten, Todd Sherer, Kenneth Marek, Claudio Soto the Parkinson’s Progression Markers Initiative
doi: https://doi.org/10.1101/2023.02.27.23286156
Back to top
Posted March 01, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Assessment of heterogeneity and disease onset in the Parkinson’s Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional study
Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, Carly M. Farris, Yihua Ma, Paula A. Urenia, Hieu Nguyen, Roy N. Alcalay, Lana M. Chahine, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, John Seibyl, Tanya Simuni, Caroline M. Tanner, Daniel Weintraub, Aleksandar Videnovic, Seung Ho Choi, Ryan Kurth, Chelsea Caspell-Garcia, Christopher S. Coffey, Mark Frasier, Luis M. A. Oliveira, Samantha J. Hutten, Todd Sherer, Kenneth Marek, Claudio Soto
medRxiv 2023.02.27.23286156; doi: https://doi.org/10.1101/2023.02.27.23286156
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area